TGF-β type I receptor inhibitor (TEW-7197) diminishes myeloma progression by multiple immunomodulatory mechanisms in combination with ixazomib

被引：1
|
作者：
Kim, Byung-Gyu
Sergeeva, Olga
Luo, George
Choi, Sung Hee
Lee, Zhenghong
Kim, Seong-Jin
Letterio, John
Malek, Ehsan
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-2647
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2647
引用
收藏
页数：2
相关论文
共 41 条
  • [21] Increase in tumour permeability following TGF-β type I receptor-inhibitor treatment observed by dynamic contrast-enhanced MRI
    Minowa, T.
    Kawano, K.
    Kuribayashi, H.
    Shiraishi, K.
    Sugino, T.
    Hattori, Y.
    Yokoyama, M.
    Maitani, Y.
    BRITISH JOURNAL OF CANCER, 2009, 101 (11) : 1884 - 1890
  • [22] SKI2162, an inhibitor of the TGF-β type I receptor (ALK5), inhibits radiation-induced fibrosis in mice
    Park, Jin-hong
    Ryu, Seung-Hee
    Choi, Eun Kyung
    Ahn, Seung Do
    Park, Euisun
    Choi, Kyung-Chul
    Lee, Sang-wook
    ONCOTARGET, 2015, 6 (06) : 4171 - 4179
  • [23] Inhibition of transforming growth factor (TGF)-β1-induced extracellular matrix with a novel inhibitor of the TGF-β type I receptor kinase activity:: SB-431542
    Laping, NJ
    Grygielko, E
    Mathur, A
    Butter, S
    Bomberger, J
    Tweed, C
    Martin, W
    Fornwald, J
    Lehr, R
    Harling, J
    Gaster, L
    Callahan, JF
    Olson, BA
    MOLECULAR PHARMACOLOGY, 2002, 62 (01) : 58 - 64
  • [24] Targeting the blood-brain barrier disruption in hypertension by ALK5/ TGF-? type I receptor inhibitor SB-431542 and dynamin inhibitor dynasore
    Atis, Muge
    Akcan, Ugur
    Altunsu, Deniz
    Ayvaz, Ecem
    Yilmaz, Canan Ugur
    Sarikaya, Deniz
    Temizyurek, Arzu
    Ahishali, Bulent
    Girouard, Helene
    Kaya, Mehmet
    BRAIN RESEARCH, 2022, 1794
  • [25] SB-431542, a specific inhibitor of the TGF-β type I receptor inhibits hypoxia-induced proliferation of pulmonary artery adventitial fibroblasts
    Yuan, Wendan
    Liu, Wei
    Cai, Hongjing
    Sun, Xuhong
    Yang, Dongxia
    Xu, Fang
    Jin, Changzhu
    PHARMAZIE, 2016, 71 (02): : 94 - 100
  • [26] An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition
    Park, Chul-Yong
    Min, Kyung Nan
    Son, Jee-Yeon
    Park, So-Yeon
    Nam, Jeong-Seok
    Kim, Dae-Kee
    Sheen, Yhun Yhong
    CANCER LETTERS, 2014, 351 (01) : 72 - 80
  • [27] SM16, an orally active TGF-β type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model
    Fu, Kai
    Corbley, Michael J.
    Sun, Lihong
    Friedman, Jessica E.
    Shan, Feng
    Papadatos, James L.
    Costa, Donald
    Lutterodt, Frank
    Sweigard, Harry
    Bowes, Scott
    Choi, Michael
    Boriack-Sjodin, P. Ann
    Arduini, Robert M.
    Sun, Dongyu
    Newman, Miki N.
    Zhang, Xiamei
    Mead, Jonathan N.
    Chuaqui, Claudio E.
    Cheung, H. -Kam
    Zhang, Xin
    Cornebise, Mark
    Carter, Mary Beth
    Josiah, Serene
    Singh, Juswinder
    Lee, Wen-Cherng
    Gill, Alan
    Ling, Leona E.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (04) : 665 - 671
  • [28] Transforming Growth Factor (TGF)-β Type I Receptor Kinase (ALK5) Inhibitor Alleviates Profibrotic TGF-β1 Responses in Fibroblasts Derived from Peyronie's Plaque
    Piao, Shuguang
    Choi, Min Ji
    Tumurbaatar, Munkhbayar
    Kim, Woo Jean
    Jin, Hai-Rong
    Shin, Sun Hwa
    Tuvshintur, Buyankhuu
    Yin, Guo Nan
    Song, Jae Sook
    Kwon, Mi-Hye
    Lee, Sang-Jin
    Han, Jee-Young
    Kim, Seong-Jin
    Ryu, Ji-Kan
    Suh, Jun-Kyu
    JOURNAL OF SEXUAL MEDICINE, 2010, 7 (10): : 3385 - 3395
  • [29] Regulation of endothelial barrier function by TGF-β type I receptor ALK5: Potential role of contractile mechanisms and heat shock protein 90
    Antonov, Alexander S.
    Antonova, Galina N.
    Fujii, Makiko
    Ten Dijke, Peter
    Handa, Vaishali
    Catravas, John D.
    Verin, Alexander D.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2012, 227 (02) : 759 - 771
  • [30] Safety and preliminary antitumor activity of the transforming growth factor beta (TGF-β) receptor I kinase inhibitor, vactosertib, in combination with paclitaxel in patients with metastatic gastric adenocarcinoma.
    Jung, Minkyu
    Lee, Choong-Kun
    Kim, Hyo Song
    Ock, Chan-Young
    Bum, Jin
    Lee, Jin
    Kang, Dong Woo
    Hwang, Sunjin
    Kim, Seong-Jin
    Chung, Hyun Cheol
    Rha, Sun Young
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345